Diethylnitrosamine (DEN) was injected into fertilized turkey eggs. After incubation for 24 days, the livers of the embryos were removed and investigated by means of histological and enzyme-histochemical methods. Doses of 2 and 5 mg DEN per egg had no effect on mortality and embryo weight but induced various types of foci of altered hepatocytes. In addition, a replacement of the trabecular structure of the liver by a tubular arrangement of the hepatocytes and markedly enlarged hepatocytes were found. The diethylnitrosamine-induced foci of altered hepatocytes were very similar to the preneoplastic lesions that occur in the liver of mammals during hepatocarcinogenesis and are regarded as early indicators of carcinogenicity. The presented in ovo model is a simple (1 dose), rapid (24 days), and inexpensive (no animal housing) approach for the induction of foci of altered hepatocytes. The sensitivity of this carcinogenesis bioassay appears to be comparable to that of lifetime studies in rodents. It is proposed that the induction of preneoplastic foci of altered hepatocytes in ovo is a valuable screening model for hepatocarcinogenic effects.
Bannasch P. (1968). The cytoplasm of hepatocytes during carcinogenesis. Electron and light microscopical investigations of the nitrosomorpholine-intoxicated rat liver. Rec. Res. Cancer Res. 19: 1-100.
2.
Bannasch P. (1986). Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis7: 689-695.
3.
Bannasch P., Enzmann H., Klimek F., Weber E., and Zerban H. (1989). Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis. Toxicol. Pathol. 17:617-629.
4.
Bannasch P., and Müller HA (1964). Lichtmikroskopische Untersuchungen über die Wirkung von N-Nitrosomorpholin auf die Leber von Ratte und Maus. Arzneimittel-Forsch. 14: 805-814.
5.
Bannasch P., and Zerban H. (1992). Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. In: Mechanisms of Carcinogenesis in Risk Identification, H Vainio, PN Magee, DB McGregor , and AJ McMichel (eds). IARC, Lyon, pp. 389-427.
6.
Benner U., Hacker HJ, and Bannasch P. (1975). Electron microscopical demonstration of glucose-6-phosphatase in native cryostat sections fixed with glutaraldehyde through semipermeable membranes. Histochemistry65: 41-47.
7.
Buchmann A., Kuhlmann W., Schwarz M., Kunz W., Wolf CR, Moll E., Friedberg T., and Oesch F. (1985). Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis6: 513-521.
8.
Enzmann H., and Bannasch P. (1987). Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis8:1607-1612.
9.
Enzmann H., Kaliner G., Watta-Gebert B., and Löser E. (1992). Foci of altered hepatocytes induced in embryonal turkey liver. Carcinogenesis13: 943-946.
10.
Enzmann H., Ohlhauser D., Dettler T., Benner U., Hacker HJ, and Bannasch P. (1989). Unusual histochemical pattern in preneoplastic hepatic foci characterized by hyperactivity of several enzymes. Virchows Arch. B (Cell Pathol.)57: 99-108.
11.
Enzmann H., Zerban H., Löser E., and Bannasch P. (1992). Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats. Virchows Arch. B62: 3-8.
12.
Farber E., and Sarma DSR (1987). Hepatocarcinogenesis : A dynamic cellular perspective . Lab. Invest. 56:4-22.
13.
Hacker HJ, Moore MA, Mayer D., and Bannasch P. (1982). Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis3: 1265-1272.
14.
Hacker HJ, Seelmann-Eggebert G., Klimek F., Peschke P., and Kletzien RF (1988). Histochemical analysis of hepatocarcinogenesis . In: Experimental Hepatocarcinogenesis, MB Roberfroid and V Preat (eds). Plenum, New York.
15.
Hacker HJ, Steinberg P., Toshkov I., Oesch F., and Bannasch P. (1992). Persistence of the cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis13: 271-276.
Ito N., Imaida K., Hasegawa R., Tsuda H. (1989). Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis. Crit. Rev. Toxicol. 19: 385-415.
18.
Ito N., Tatematsu M., Hasegawa R., and Tsuda H. (1989). Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P positive liver cell focus as an endpoint marker. Toxicol. Pathol. 17: 630-641.
19.
Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa S., Kagawa M., Ogiso T., Masui T., Imaida K., Fukushima S., and Asamoto M. (1988). Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-An approach for a new medium-term bioassay system. Carcinogenesis9:387-394.
20.
Kalengayi MMR and Desmet VJ (1975). Sequential histological and histochemical study of the rat liver during aflatoxin B,-induced carcinogenesis . Cancer Res. 35: 2845-2852.
21.
Klimek F., Moore MA, Schneider E., and Bannasch P. (1988). Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver. Histochemistry90: 37-42.
22.
Lijinsky W. , Reuber MD, and Riggs CW (1981). Dose response studies of carcinogenesis in rats by nitrosodiethylamine. Cancer Res . 41: 4997-5003.
23.
Maronpot RR , Pitot HC, and Peraino C. (1989). Use of rat liver altered focus models for testing chemicals that have completed two-year carcinogenicity studies. Toxicol. Pathol. 17: 651-662.
24.
Mayer D., and Schäfer B. (1982). Biochemical and morphological characterization of glycogen-storing epithelial liver cell lines. Exp. Cell Res. 138: 1-14.
25.
Meijer Aefh and de Vries GP (1974). Semipermeable membranes for improving the histochemical demonstration of enzyme activities in tissue sections. IV. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (decarboxylating). Histochemistry40: 349-359.
26.
Moore MA, Hacker HJ, and Bannasch P. (1983). Phenotypic instability in focal and nodular lesions induced in a short-term system in the rat liver. Carcinogenesis4: 595-603.
27.
Moore MA, Mayer D., and Bannasch P. (1982). The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis3: 1429-1436.
28.
Oesterle D. , Gerbracht U., Deml E., Schlatterer B., and Eigenbrodt E. (1989). Comparison of three rat liver foci bioassays-Incidence of preneoplastic foci initiated by diethylnitrosamine. Carcinogenesis10: 1891-1895.
29.
Peraino C., Staffeldt EF, Carnes BA, Ludeman VA, Blomquist JA, and Vesselinovitch SD (1984). Characterization of histochemically detectable altered hepatocyte foci and their relationship to nepauc tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res. 44: 3340-3347.
30.
Pereira MA and Herren-Freund SL (1988). Liver initiation assay: the rat liver foci bioassay of carcinogens and noncarcinogens. In: Evaluation of Short- Term Tests for Carcinogens, J Ashby, FJ de Serres , MD Shelby, BH Margolin , M Ishidate, GC Becking (eds). Cambridge University Press, New York, pp. 1.325-1.328.
31.
Pitot HC (1990). Altered hepatic foci: Their role in murine hepatocarcinogenesis . Annu. Rev. Pharmacol. Toxicol. 30: 465-500.
32.
Pitot HC, Goldsworthy TL, Moran S., Kennan W., Glauert HP, Maronpot RR, and Campbell HA (1987). A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationship to altered hepatic foci. Carcinogenesis8 : 1491-1499.
33.
Pitot HC and Sirica AE (1980). The stages of initiation and promotion in hepatocarcinogenesis . Biochim. Biophys. Acta605: 191-215.
34.
Ruan Y., Hacker HJ, Zerban H., and Bannasch P. (1989). Ultrastructural and immunocytochemical characterization of the cellular phenotype in primary adenoid liver tumours of the rat. Path. Res. Pract. 184: 223-233.
35.
Seelmann-Eggebert G., Mayer D., Mecke D., and Bannasch P. (1987). Expression and regulation of glycogen phosphorylase in preneoplastic and neoplastic hepatic lesions in rats. Virchows Arch. B53: 44-51.
36.
Solt D. and Farber E. (1976). New principle for the analysis of chemical carcinogenesis . Nature263:701-703.
37.
Tatematsu M. , Nagamine Y., and Farber E. (1983). Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res. 43: 5049-5058.
38.
Thung SN (1990). The development of proliferating ductular structures in liver disease. Arch. Pathol. Lab. Med. 114: 407-411.
39.
Tsuda H., Masui T., Ikawa E., Imaida K., and Ito N. (1987). Compared promoting potential of D-galactosamine, carbon tetrachloride and partial hepatectomy in rapid induction of preneoplastic liver lesions in the rat. Cancer Lett. 37: 163-171.
40.
Vandersteenhoven AM, Burchette J., and Michalopoulos G. (1990). Characterization of ductular hepatocytes in end-stage cirrhosis. Arch. Pathol. Lab. Med. 114: 403-406.
41.
Wachstein M. , and Meisel E. (1957). Histochemistry of hepatic phosphatases at a physiological pH with special reference to the demonstration of bile canaliculi. Am. J. Clin. Pathol. 27: 13-23.
42.
Weber E., and Bannasch P. (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia induced by single oral exposures to N-nitrosomorpholine . Carcinogenesis15: 1219-1226.
43.
Weber E., and Bannasch P. (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine. Carcinogenesis15: 1227-1234.
44.
Weber E., and Bannasch P. (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia induced by continuous oral exposures to N-nitrosomorpholine . Carcinogenesis15: 1235-1242.
45.
Williams GM (1989). The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol. Pathol. 17:663-673.
46.
Williams GM and Watanabe K. (1978). Quantitative kinetics of development of N-2-flourenylacetamideinduced altered hyperplastic hepatocellular foci resistant to iron accumulation and their reversion or persistence following removal of carcinogen. J. Natl. Cancer Inst. 61: 113-121.
47.
Zerban H., Radig S., Kopp-Schneider A., and Bannasch P. (1994). Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotype cellular diversity and instability. Carcinogenesis15: 2467-2473.
